I thought the same. You normally want to raise funds at the highest possible price. But to fund a swap, it makes more sense to do it at the bottom. The rewards will be more and then with more cash, less need to raise funds later
Thank you for your research .I always enjoyed you post.i believed also the news today is positive.sareum is really for the long term holder. Drug take time to get to market But sar is doing a great job. Thank and good luck all.
Thanks so much for your clear understanding and research. It would seem we are moving slowly but surely in the right direction. I've been adding over the last few months and have to say I am more confident after today's news. As always, time will tell.
Whilst it's admirable various institutions have participated and are participating in tests nobody yet has really spent very much on development, the sorts of sums required to fast track SARs technology is small change to most of the medium let alone large pharma companies. SAR's products have been in the shop window for ten years and all they have to show for it so far is some nominal interest from various research institutes. We had test results back in 2011 which showed dramatic results on tumor reduction, what did Tim do, issue a "no reason RNS" as he has done on other occasions, he should have been shouting it from the rooftops. This companies share price should by now be well into the 5p+ range if they truly had something and not having to issue more shares to Wonga, as they have today, at 0.5p.. Just my thoughts and I'll go away now and continue watching from the sidelines.. gl. andy.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.